WEBSITECHANGES

Website Changes

---

06/02/2009

New videos added to the Virtualtrials.com video library!

---

06/01/2009

Al Musella (President Of the Musella Foundation) to receive "Voices" award on Thursday, June 4th in NYC!

---

06/01/2009

TransMolecular Presents New Data Highlighting the Anti-angiogenic and Tumor-targeting Properties of TM601 at ASCO Annual Meeting

---

06/01/2009

Drug Made From Cottonseed May Slow Brain Cancer, Researchers Say

---

06/01/2009

Most common brain cancer may originate in neural stem cells

---

06/01/2009

Pfizer and Celldex Therapeutics Present Update on CDX-110 (PF-04948568) Phase 2 Brain Cancer Studies at 45th Annual ASCO Meeting

---

06/01/2009

Added a few videos to the video library.. More will be added soon!

---

06/01/2009

Updated survivor story Tom K

---

05/28/2009

Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program

---

05/28/2009

Common Cancer Drug (Avastin) May Increase Risk of Deadly GI Perforations

---

05/27/2009

Amber Alert: Pennsylvania

---

05/26/2009

Call for support: Senator Kennedy`s Cancer Bill (S. 717 called 21st Century Cancer ALERT-

---

05/25/2009

Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery

---

05/25/2009

Brain Tumor Talk Radio

---

05/24/2009

IBTA E-News May 24 2009

---

05/22/2009

Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors.

---

05/14/2009

Very late relapses in glioblastoma long-term survivors.

---

05/14/2009

---

05/14/2009

ASCO Abstracts now available online!

---

05/14/2009

A phase II study of chemoradiation followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma: 12- and 18-month survival data (NABTT 0501).

---

05/14/2009

Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity.

---

05/14/2009

Epidermal growth factor receptor variant III (EGFRvIII) vaccine (CDX-110) in GBM.

---

05/14/2009

Targeting brain tumor stem cells using a bispecific antibody directed against CD133+ and EGFRvIII+.

---

05/14/2009

A phase I trial of tumor-associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glioblastoma.

---

05/14/2009

A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma.

---